Clinical Trials Logo

Acute Gastritis clinical trials

View clinical trials related to Acute Gastritis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04341454 Completed - Chronic Gastritis Clinical Trials

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

Start date: June 2, 2020
Phase: Phase 3
Study type: Interventional

The purpose of study is to confirm the efficacy of DWP14012 X mg QD, DWP14012 Y mg BID compared to placebo in patients with Acute or Chronic Gastritis

NCT ID: NCT04189705 Completed - Chronic Gastritis Clinical Trials

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

Start date: December 30, 2019
Phase: Phase 3
Study type: Interventional

This is a multi-center, randomized, double-blind, active-controlled, non-inferiority, phase 3 study to evaluate the efficacy and safety of MCT-SR in patients with gastritis.

NCT ID: NCT04066530 Completed - Chronic Gastritis Clinical Trials

A Study to Evaluate the Efficacy and Safety of AD-203

Start date: September 23, 2019
Phase: Phase 3
Study type: Interventional

This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab. in patients with acute or chronic gastritis

NCT ID: NCT02356679 Completed - Chronic Gastritis Clinical Trials

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

Start date: August 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients.

NCT ID: NCT01817556 Completed - Chronic Gastritis Clinical Trials

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

Start date: October 2012
Phase: Phase 4
Study type: Interventional

This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients with acute or chronic gastritis. Subject will receive Stillen tab or Mucosta tab., three times a day for four weeks.

NCT ID: NCT01190657 Completed - Gastric Ulcer Clinical Trials

Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer

Start date: May 2010
Phase: Phase 4
Study type: Interventional

This is a self-controlled, open, multiple-center clinical trial.